# PPV-06 Vaccine in Inflammatory Knee Osteoarthritis

> **NCT06605963** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Peptinov SAS** · enrollment: 204 (estimated)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** PPV-06
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06605963
- **Lead sponsor:** Peptinov SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06605963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06605963, "PPV-06 Vaccine in Inflammatory Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06605963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*